Ronald Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 01-01-2025
- Paid Up Capital ₹ 8.50 M
as on 01-01-2025
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 25.44 Cr
as on 01-01-2025
- Satisfied Charges ₹ 21.00 Cr
as on 01-01-2025
- Revenue 2.29%
(FY 2023)
- Profit 137.71%
(FY 2023)
- Ebitda 160.57%
(FY 2023)
- Net Worth 56.59%
(FY 2023)
- Total Assets 16.16%
(FY 2023)
About Ronald Pharmaceuticals
The Corporate was formerly known as Dupont Organics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 8.50 M.
The company currently has active open charges totaling ₹25.44 Cr. The company has closed loans amounting to ₹21.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nandkishore Maheshwari and Vedant Maheshwari serve as directors at the Company.
- CIN/LLPIN
U24110GJ1993PTC019347
- Company No.
019347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ronald Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandkishore Maheshwari  | Director | 20-Jul-2012 | Current |
| Vedant Maheshwari | Director | 20-Jul-2012 | Current |
Financial Performance of Ronald Pharmaceuticals.
Ronald Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.29% increase. The company also saw a substantial improvement in profitability, with a 137.71% increase in profit. The company's net worth Soared by an impressive increase of 56.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ronald Pharmaceuticals?
Unlock access to Ronald Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Savorite Pharmaceuticals Private LimitedActive 6 years 10 daysNandkishore Maheshwari and Vedant Maheshwari are mutual person
Mypher Pharmaceuticals LlpActive 10 years 3 monthsNandkishore Maheshwari and Vedant Maheshwari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 27 Jun 2024 | ₹10.81 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Mar 2023 | ₹1.01 M | Open |
Others Creation Date: 29 Jun 2020 | ₹4.96 Cr | Open |
How Many Employees Work at Ronald Pharmaceuticals?
Unlock and access historical data on people associated with Ronald Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ronald Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ronald Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
